Impaired perforin-dependent NK cell cytotoxicity and proliferative activity of peripheral blood T cells is associated with metastatic melanoma

Tumori

Volumn 87, Issue 5, 2001, Pages 324-329

  Jovic V ^a   Konjevic G ^a   Radulovic S ^a   Jelic S ^a   Spuzic I ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Activation antigens; Metastatic melanoma; NK cells; Perforin mediated cytoto xicity; T cells

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHROMIUM 51; HLA DR ANTIGEN; IMMUNOMODULATING AGENT; MITOGENIC AGENT; PERFORIN; PHYTOHEMAGGLUTININ;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER CHEMOTHERAPY; CELL ACTIVITY; CELL FUNCTION; CELL PROLIFERATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNE RESPONSE; IMMUNOSTIMULATION; IMMUNOTHERAPY; MALE; MELANOMA; METASTASIS; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; T LYMPHOCYTE ACTIVATION; TUMOR CELL;

EID: 0035203917     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160108700509     Document Type: Article

References (50)

1. The role of natural killer cells in immune surveillance of cancer
2. Lymphokine activated killer cells
3. Two roles of CD4 cells in the control of generation of cytotoxic T lymphocytes
4. The central role of CD4+ T cells in the antitumor immune response
5. Irreversible cancer cellinduced functional anergy and apoptosis in resting and activated NK cells
6. Type I interferons keep activated T cells alive
7. An essential role for tumor necrosis factor in NK cell-mediated tumor rejection in the peritoneum
8. Perforin is a major contributor to NK cell control of tumor metastasis
9. Xenospecific cytotoxic T lymphocytes: Potent lysis in vitro and in vivo
10. Decreased tumor surveillance in perforin-deficient mice
11. Flow cytometry evaluation of lymphocyte subsets in non-treated neoplastic patients
12. Phenotypic and functional profile of peripheral blood mononuclear cells isolated from melanoma patients undergoing combined immunotherapy and chemotherapy
13. Natural killer (NK) cell activity in the peripheral blood of patients with malignant diseases: Melanoma, carcinoma, chronic and acute lymphatic leukemia
14. Defective interferon-augmented natural killer cell activity in patients with metastatic malignant melanoma
15. Preparation, staining and analysis by flow cytometry of peripheral blood leukocytes
16. The proliferation and function of human mononuclear leukocytes and natural killer cells in serum-free medium
17. Effect of aluminium chloride on mitogenesis, mitosis and cell cycle in human short-term whole blood cultures: Lower concentrations enhance mitosis
18. Defects in natural killer cell activity and interferon response in human lung carcinoma and malignant melanoma
19. Diminished natural killer-cell activity of interstitial pulmonary cell populations from patients with carcinoma of the lung
20. The difference in NK-cell activity between patients with non-Hodgkin's lymphomas and Hodgkin's disease
21. Natural killer activity in patients with malignant melanoma
22. Stage dependence of NK cell activity and its modulation by interleukin 2 in patients with breast cancer
23. Therapeutic implications of the kinetics of immunomodulation during single or combined treatment of melanoma patients with dacarbazine and interferon-alpha
24. Defective natural cytotoxicity in patients with cancer: Normal number of effector cells but decreased recycling capacity in patients with advanced disease
25. Utility of flow cytometric detection of CD 69 expression as a rapid method for determining polyand oligoclonal lymphocyte activation
26. Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12
27. Involvement of Fas ligand and Fas-mediated pathway in the cytotoxicity of human natural killer cells
28. Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity
29. Perforin dependence of natural killer cell-mediated tumor control in vivo
30. Different alteration in lactate dehydrogenase activity and profile of peripheral blood mononuclear cells in Hodgkin's and non-Hodgkin's lymphomas
31. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice
32. Membrane permeability transporters and channels: From disease to structure and back
33. Pivotal role of endogenous TNF-alpha in the induction of functional inactivation and apoptosis in NK cells
34. A comparison of the NK cell cytotoxicity with effects of TNF-α against K-562 cells, determined by LDH release assay
35. Natural cytotoxicity and interferon production in human cancer: Deficient natural killer activity and normal interferon production in patients with advanced disease
36. Phenotypic and functional analyses of natural killer cells: Impaired NK activity partly due to the CD56+ cell dysfunction in cancer patients
37. Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defects
38. Impaired NK response of cancer patients to IFN-α but not to IL-2: Correlation with serum immunosuppressive acidic protein (IAP) and role of suppressor macrophage
39. Tumor-induced immune dysfunction: The macrophage connection
40. The CD69 receptor: Multipurpose cell surface trigger for hematopoietic cells
41. CD69 is a stimulatory receptor for natural killer cell and its cytotoxic effect is blocked by CD94 inhibitory receptor
42. Flow cytometry analysis of peripheral blood lymphocytes in patients with choroidal melanoma
43. T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients
44. The host-tumor immune conflict: From immunosuppression to resistance and destruction
45. Downregulation of interleukin-12 (IL- 12) responsiveness in human T cells by transforming growth factor-beta: Relationship with IL-12 signaling
46. Quantitative analysis of Th1, Th2 and TGF-betal cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients
47. Human pulmonary macrophages utilize prostaglandins and transforming growth factor beta 1 to suppress lymphocyte activation
48. Alterations in T cell receptor and signal transduction molecules in melanoma patients
49. Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer
50. Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients